Antibody Treatments, Though Promising, Will Be in Short Supply

All the weak points of American health care — testing delays, communication breakdowns, inequity — are working against this potential treatment.
By BY KATIE THOMAS from NYT Health https://ift.tt/2Hhyz4u
via IFTTT
your-feed-science, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Remdesivir (Drug), Clinical Trials, Hospitals, Antibodies, Elderly, your-feed-healthcare
Source New York Times
Làm đẹp Blog 247